Pernille Ravn

8.2k total citations
132 papers, 5.1k citations indexed

About

Pernille Ravn is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Pernille Ravn has authored 132 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Epidemiology, 81 papers in Infectious Diseases and 43 papers in Surgery. Recurrent topics in Pernille Ravn's work include Tuberculosis Research and Epidemiology (76 papers), Mycobacterium research and diagnosis (45 papers) and Pneumonia and Respiratory Infections (32 papers). Pernille Ravn is often cited by papers focused on Tuberculosis Research and Epidemiology (76 papers), Mycobacterium research and diagnosis (45 papers) and Pneumonia and Respiratory Infections (32 papers). Pernille Ravn collaborates with scholars based in Denmark, United Kingdom and Germany. Pernille Ravn's co-authors include Peter Andersen, Morten Rühwald, Inger Brock, Jesper Eugen‐Olsen, Martine G. Aabye, Ida Rosenkrands, Karin Weldingh, Else Marie Agger, Laurens A.H. van Pinxteren and J.M. Pollock and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and PLoS ONE.

In The Last Decade

Pernille Ravn

128 papers receiving 4.9k citations

Peers

Pernille Ravn

EPIDE

SURGE

IMMUN

Alphonse Okwera Uganda

Gerald H. Mazurek United States

José Domínguez Spain

P R Narayanan India

Jeffrey R. Starke United States

Alfredo Ponce‐de‐León Mexico

Andrea Gori Italy

Sahil Khanna United States

Hans L. Rieder France

Julián Torre‐Cisneros Spain

Alphonse Okwera Uganda

Pernille Ravn

3.6k ×0.9

2.9k ×0.8

EPIDE

1.5k ×0.8

SURGE

536 ×0.5

IMMUN

287 ×0.5

Citations per year, relative to Pernille Ravn Pernille Ravn (= 1×) peers Alphonse Okwera

Countries citing papers authored by Pernille Ravn

Since Specialization

Citations

This map shows the geographic impact of Pernille Ravn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pernille Ravn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pernille Ravn more than expected).

Fields of papers citing papers by Pernille Ravn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pernille Ravn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pernille Ravn. The network helps show where Pernille Ravn may publish in the future.

Co-authorship network of co-authors of Pernille Ravn

This figure shows the co-authorship network connecting the top 25 collaborators of Pernille Ravn. A scholar is included among the top collaborators of Pernille Ravn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pernille Ravn. Pernille Ravn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fally, Markus, et al.. (2025). Impact of pneumococcal urinary antigen testing on clinical outcomes in patients hospitalized with community-acquired pneumonia. European Journal of Clinical Microbiology & Infectious Diseases. 44(11). 2635–2644.

Fally, Markus, Simone Bastrup Israelsen, Thomas Benfield, et al.. (2024). The Impact of Lower Respiratory Tract Sample Cultures on Outcomes in Community-Acquired Pneumonia: A Propensity Score–Matched Cohort Study. Clinical Infectious Diseases. 81(6). 1152–1158. 1 indexed citations

Israelsen, Simone Bastrup, Andreas Dehlbæk Knudsen, Birgitte Lindegaard, et al.. (2023). Short-course antibiotic therapy of 5 days in community-acquired pneumonia (CAP5): study protocol for a randomised controlled trial. BMJ Open. 13(7). e069013–e069013. 2 indexed citations

Ravn, Pernille, et al.. (2019). Fast-track pneumonia pathway focusing on early progressive mobilisation: a clinical feasibility study. ERJ Open Research. 5(1). 12–2019. 5 indexed citations

Egelund, Gertrud Baunbæk, Andreas Vestergaard Jensen, Stine Bang Andersen, et al.. (2019). Is chronic obstructive pulmonary disease a risk factor for death in patients with community acquired pneumonia?. Infectious Diseases. 51(5). 340–347. 15 indexed citations

Precht, Helle, Dennis Lund Hansen, Anders Tingberg, et al.. (2019). Comparison of image quality in chest, hip and pelvis examinations between mobile equipment in nursing homes and static indirect radiography equipment in the hospital. Radiography. 26(2). e31–e37. 13 indexed citations

Wejse, Christian, Troels Lillebæk, Ole Kirk, et al.. (2017). [The current global tuberculosis state].. PubMed. 179(20). 1 indexed citations

Vestergaard, Lasse S, Marie Helleberg, Michala Vaaben Rose, et al.. (2016). Performance of Interferon-Gamma and IP-10 Release Assays for Diagnosing Latent Tuberculosis Infections in Patients with Concurrent Malaria in Tanzania. American Journal of Tropical Medicine and Hygiene. 94(4). 728–735. 7 indexed citations

Lillebæk, Troels, et al.. (2016). Prognostic value of interferon-γ release assays, a population-based study from a TB low-incidence country. Thorax. 71(7). 652–658. 11 indexed citations

10.

Nissen, Thomas Nørrelykke, Michala Vaaben Rose, Godfather Kimaro, et al.. (2012). Challenges of Loss to Follow-up in Tuberculosis Research. PLoS ONE. 7(7). e40183–e40183. 12 indexed citations

11.

Aabye, Martine G., et al.. (2012). A Simple Method to Quantitate IP-10 in Dried Blood and Plasma Spots. PLoS ONE. 7(6). e39228–e39228. 38 indexed citations

12.

Bjerrum, Stephanie, et al.. (2012). Primary health care staff's perceptions of childhood tuberculosis: a qualitative study from Tanzania. BMC Health Services Research. 12(1). 6–6. 21 indexed citations

13.

Lange, Christoph, Martina Sester, Giovanni Sotgiu, et al.. (2011). Interferon-γ release assays for diagnosis of active pleural tuberculosis: a developing world perspective. European Respiratory Journal. 38(3). 747–748. 5 indexed citations

14.

Rühwald, Morten, Irene Latorre, José Maldonado, et al.. (2011). Specific diagnosis of tuberculosis infection sent via mail – IGRAs on paper. European Respiratory Journal. 38(Suppl 55). 1897–1897. 1 indexed citations

15.

Rühwald, Morten, José Domínguez, Irene Latorre, et al.. (2011). A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis. 91(3). 260–267. 97 indexed citations

16.

Bélard, Erika, Morten Rühwald, Bolette Søborg, et al.. (2011). Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection. Inflammatory Bowel Diseases. 17(11). 2340–2349. 100 indexed citations

17.

Aabye, Martine G., Pernille Ravn, George PrayGod, et al.. (2009). The Impact of HIV Infection and CD4 Cell Count on the Performance of an Interferon Gamma Release Assay in Patients with Pulmonary Tuberculosis. PLoS ONE. 4(1). e4220–e4220. 80 indexed citations

18.

Petrucci, Roberta, Ricardo Queiroz Gurgel, Jeevan Bahadur Sherchand, et al.. (2008). Interferon Gamma, Interferon-Gamma-Induced-Protein 10, and Tuberculin Responses of Children at High Risk of Tuberculosis Infection. The Pediatric Infectious Disease Journal. 27(12). 1073–1077. 40 indexed citations

19.

Rühwald, Morten, et al.. (2008). Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. European Respiratory Journal. 32(6). 1607–1615. 156 indexed citations

20.

Ravn, Pernille, et al.. (1995). Effects of isoniazid treatment on human lymphocyte proliferative response, lymphocyte subsets and natural killer cell activity. Immunopharmacology. 30(3). 247–253. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact